Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02187666
Other study ID # NOC 1001
Secondary ID
Status Recruiting
Phase N/A
First received July 9, 2014
Last updated July 9, 2014
Start date December 2011

Study information

Verified date July 2014
Source DC2 Healthcare
Contact Christina R Cook, PhD
Phone 615-712-9574
Email ccook@dc2healthcare.com
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational [Patient Registry]

Clinical Trial Summary

The primary objective of the Spine Registry is to enhance the understanding of spinal disease and treatment of spinal disease with the goal of guiding treatment options.


Description:

This study will enhance the understanding of the variability, progression and treatment of spinal disease with the ultimate goal of better guiding and assessing therapeutic intervention. Researchers will collect complications and safety following cervical and lumbar surgeries to determine best options for patients. Prospective reports will be collected on patients undergoing lumbar or cervical spinal surgery. Patients will be enrolled in registry after signing informed consent. Data will be collected at various time points. The registry will serve as a database of cervical and lumbar surgeries in which retrospective analysis and exploratory analysis of specific research questions can be answered.


Recruitment information / eligibility

Status Recruiting
Enrollment 10000
Est. completion date
Est. primary completion date December 2016
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- Patients undergoing lumbar or cervical surgery

- Understand and sign informed consent

Exclusion Criteria:

- There are no specific exclusion criteria

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
United States DC2 Healthcare Nashville Tennessee

Sponsors (3)

Lead Sponsor Collaborator
DC2 Healthcare National Neurosurgical and Orthopedic Optimum Care Continuum (NOC2), National Research Independent Operations Management

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Visual Analogue Scale (VAS) from baseline at 4 weeks Pain intensity scale taken at baseline and 4 weeks after surgery baseline and 4 weeks after surgery No
Primary Change in Visual Analogue Scale (VAS) from baseline at 3 months Pain intensity scale taken at baseline and 3 months after surgery baseline and 3 months after surgery No
Primary Change in Visual Analogue Scale (VAS) from baseline at 6 months Pain intensity scale taken at baseline and 6 months after surgery baseline and 6 months after surgery No
Primary Change in Visual Analogue Scale (VAS) from baseline at 12 months Pain intensity scale taken at baseline and 12 months after surgery baseline and 12 months after surgery No
Primary Change in Visual Analogue Scale (VAS) from baseline at 24 months Pain intensity scale taken at baseline and 24 months after surgery baseline and 24 months after surgery No
Secondary Change from baseline in Oswestry Disability index at 4 weeks Assesses impact of disability in terms of activities of daily living. To be taken at baseline and 4 weeks after surgery. baseline and 4 weeks after surgery No
Secondary Fusion at 6 months 6 months post-op No
Secondary Length of hospital stay Date of discharge will be recorded, an average of one to three days one to three days following surgery No
Secondary Revision surgery within 30 days 30 days after surgery No
Secondary Return to work Time off of work and whether patient returned restricted or unrestricted 4 weeks after surgery No
Secondary Return to normal/usual activity Time between surgery and resuming normal activity for patient 4 weeks after surgery No
Secondary Complications 24 hours after surgery Yes
Secondary Change from baseline in Oswestry Disability index at 3 months Assesses impact of disability in terms of activities of daily living. To be taken at baseline and 3 months after surgery. baseline and 3 months after surgery No
Secondary Change from baseline in Oswestry Disability index at 6 months Assesses impact of disability in terms of activities of daily living. To be taken at baseline and 6 months after surgery. baseline and 6 months after surgery No
Secondary Change from baseline in Oswestry Disability index at 12 months Assesses impact of disability in terms of activities of daily living. To be taken at baseline and 12 months after surgery. baseline and 12 months after surgery No
Secondary Change from baseline in Oswestry Disability index at 24 months Assesses impact of disability in terms of activities of daily living. To be taken at baseline and 24 months after surgery. baseline and 24 months after surgery No
Secondary Return to work Time off of work and whether patient returned restricted or unrestricted 3 months after surgery No
Secondary Return to work Time off of work and whether patient returned restricted or unrestricted 6 months after surgery No
Secondary Return to work Time off of work and whether patient returned restricted or unrestricted 12 months after surgery No
Secondary Return to work Time off of work and whether patient returned restricted or unrestricted 24 months after surgery No
Secondary Return to normal/usual activity Time between surgery and resuming normal activity for patient 3 months after surgery No
Secondary Return to normal/usual activity Time between surgery and resuming normal activity for patient 6 months after surgery No
Secondary Return to normal/usual activity Time between surgery and resuming normal activity for patient 12 months after surgery No
Secondary Return to normal/usual activity Time between surgery and resuming normal activity for patient 24 months after surgery No
Secondary Complications 4 weeks after surgery Yes
Secondary Complications 3 months after surgery Yes
Secondary Complications 6 months after surgery Yes
Secondary Complications 12 months after surgery Yes
Secondary Complications 24 months after surgery Yes
See also
  Status Clinical Trial Phase
Completed NCT02387073 - The Efficacy of Electrical Version of Patient Reported Outcome N/A
Recruiting NCT05610098 - Gene Expression Profiles in Spinal Tuberculosis.
Recruiting NCT04120272 - Discovery for Biomarkers and Risk Factors for Postoperative Delirium in Elderly Patients With Spine Surgery
Terminated NCT04174534 - ROMEO®2 PAD. 2 YEARS PROSPECTIVE FOLLOW-UP
Enrolling by invitation NCT05181098 - Prospective Robotic-Guided Registry of Spine Surgery
Completed NCT05148637 - General Anesthesia and Regional Cerebral Oxygenation inSpine Surgery Prone Position N/A
Recruiting NCT05709782 - Phase II Cohort of Spinal Stereotactic Radiotherapy in Patients Using a MR LINAC Phase 2
Recruiting NCT06407167 - Neuropathic Pain in Patients With Degenerative Lumbar Stenosis
Completed NCT04391855 - Wound Infiltration With Tramadol, Dexmedetomidine, or Magnesium Plus Ropivacaine for Pain Relief After Spine Surgery Phase 4
Not yet recruiting NCT06393530 - Erector Spinae Plane Block for Cervical Spine Surgery Phase 4
Not yet recruiting NCT06335095 - Gait Analysis and Degenerative Spine
Enrolling by invitation NCT04364295 - Stronger Together Global Registry
Recruiting NCT06451588 - Fecal Microbiota Transplantation in Axial Spondyloarthritis Phase 2
Recruiting NCT02809950 - Effects of Preoperative Oral Carbohydrates Loading in Patients at High Risk of Postoperative Nausea and Vomiting Undergoing Spinal Surgery Phase 4
Recruiting NCT04524377 - Evaluation of the Influence of Deep Brain Stimulation on the Spinal Deformities Associated With Parkinson's Disease N/A
Completed NCT02534714 - Analysis of Hypovitaminosis D and Osteopenia/Osteoporosis in Spinal Disease Patients Who Underwent a Spinal Fusion at Illinois Neurological Institute, Peoria, IL., a Retrospective Review From November 1, 2012 to October 31, 2014 and Prospective Pilot From July 1, 2015-June 30, 2016
Terminated NCT01458938 - This Study is to Determine if Degenerative Spinal Pain and Disorders Cause the Levels of Substance P to Change in a Patients Saliva, Blood and/or Cerebrospinal Fluid. N/A
Recruiting NCT01642706 - Regulatory B Cells in Inflammatory Rheumatisms and Biomarkers of Response to Biologic Treatments
Recruiting NCT04176562 - Prospective SPINE Registry
Recruiting NCT03969602 - Cognitive Behavioral Therapy (CBT) After Lumbar Spinal Fusion in Patients With High Pain Catastrophizing N/A

External Links